This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor "Type II Error and Antidepressants"

Karen L. Weihs, Sharyn R. Batey, Trisha L. Houser, Rafe M. J. Donahue, and John A. Ascher

Published: May 1, 2001

Article Abstract

Letter to the Editor

Sir: We are grateful to Dr. Walker and colleagues for giving us the opportunity to reply to their letter regarding our article. Their major concern with our report was the omission of a power analysis.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 62

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...